Literature DB >> 27618683

Striving to cure adult T-cell leukaemia/lymphoma: a role for allogeneic stem cell transplant?

E H Phillips1, A Hodson2, O Hermine3, A Bazarbachi4, K Cwynarski1.   

Abstract

Adult T-cell leukaemia/lymphoma (ATL) is an aggressive HTLV-1-related malignancy, rare outside of regions where the retrovirus is endemic. Although the use of antiviral therapy has improved outcomes, particularly for indolent forms of ATL, response to combination chemotherapy is poor and outcomes for aggressive subtypes remains dismal. Consolidation with allogeneic stem cell transplant (alloSCT) has an increasing role in the management of ATL in eligible patients, offering favourable long-term remission rates. However, relatively high-transplant-related mortality and issues with donor recruitment for certain ethnicities remain problematic. In this review, we discuss the rationale for and issues surrounding alloSCT in ATL in the context of conventional and emerging therapies.

Entities:  

Mesh：

Year:  2016        PMID： 27618683     DOI： 10.1038/bmt.2016.154

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


  95 in total

1.  Identification of two new HLA-A*1101-restricted tax epitopes recognized by cytotoxic T lymphocytes in an adult T-cell leukemia patient after hematopoietic stem cell transplantation.

Authors:  Nanae Harashima; Ryuji Tanosaki; Yukiko Shimizu; Kiyoshi Kurihara; Takao Masuda; Jun Okamura; Mari Kannagi
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

2.  Brief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa.

Authors:  O Hermine; D Bouscary; A Gessain; P Turlure; V Leblond; N Franck; A Buzyn-Veil; B Rio; E Macintyre; F Dreyfus
Journal:  N Engl J Med       Date:  1995-06-29       Impact factor: 91.245

3.  A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303.

Authors:  Y Yamada; M Tomonaga; H Fukuda; S Hanada; A Utsunomiya; M Tara; M Sano; S Ikeda; K Takatsuki; M Kozuru; K Araki; F Kawano; M Niimi; K Tobinai; T Hotta; M Shimoyama
Journal:  Br J Haematol       Date:  2001-05       Impact factor: 6.998

4.  Impact of graft-versus-host disease on allogeneic hematopoietic cell transplantation for adult T cell leukemia-lymphoma focusing on preconditioning regimens: nationwide retrospective study.

Authors:  Takashi Ishida; Masakatsu Hishizawa; Koji Kato; Ryuji Tanosaki; Takahiro Fukuda; Yoshifusa Takatsuka; Tetsuya Eto; Yasushi Miyazaki; Michihiro Hidaka; Naokuni Uike; Toshihiro Miyamoto; Mitsuru Tsudo; Hisashi Sakamaki; Yasuo Morishima; Ritsuro Suzuki; Atae Utsunomiya
Journal:  Biol Blood Marrow Transplant       Date:  2013-09-30       Impact factor: 5.742

5.  Potential contribution of a novel Tax epitope-specific CD4+ T cells to graft-versus-Tax effect in adult T cell leukemia patients after allogeneic hematopoietic stem cell transplantation.

Authors:  Yotaro Tamai; Atsuhiko Hasegawa; Ayako Takamori; Amane Sasada; Ryuji Tanosaki; Ilseung Choi; Atae Utsunomiya; Yasuhiro Maeda; Yoshihisa Yamano; Tetsuya Eto; Ki-Ryang Koh; Hirohisa Nakamae; Youko Suehiro; Koji Kato; Shigeki Takemoto; Jun Okamura; Naokuni Uike; Mari Kannagi
Journal:  J Immunol       Date:  2013-03-08       Impact factor: 5.422

6.  Eradication of virus-infected T-cells in a case of adult T-cell leukemia/lymphoma by nonmyeloablative peripheral blood stem cell transplantation with conditioning consisting of low-dose total body irradiation and pentostatin.

Authors:  Yasunobu Abe; Shinji Yashiki; Ilseung Choi; Keiichi Hara; Takamitsu Matsushima; Junji Nishimura; Shoichi Inaba; Hajime Nawata; Koichiro Muta
Journal:  Int J Hematol       Date:  2002-07       Impact factor: 2.490

7.  Mutations of the p53 gene in adult T-cell leukemia.

Authors:  A Sakashita; T Hattori; C W Miller; H Suzushima; N Asou; K Takatsuki; H P Koeffler
Journal:  Blood       Date:  1992-01-15       Impact factor: 22.113

8.  Early application of related SCT might improve clinical outcome in adult T-cell leukemia/lymphoma.

Authors:  S Fuji; H Fujiwara; N Nakano; A Wake; Y Inoue; T Fukuda; M Hidaka; Y Moriuchi; T Miyamoto; N Uike; J Taguchi; T Eto; T Tomoyose; T Kondo; A Yamanoha; T Ichinohe; Y Atsuta; A Utsunomiya
Journal:  Bone Marrow Transplant       Date:  2015-11-02       Impact factor: 5.483

9.  Adult T-cell leukemia/lymphoma in Jamaica: 1986-1995.

Authors:  B Hanchard
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1996

10.  Development of a novel redirected T-cell-based adoptive immunotherapy targeting human telomerase reverse transcriptase for adult T-cell leukemia.

Authors:  Yukihiro Miyazaki; Hiroshi Fujiwara; Hiroaki Asai; Fumihiro Ochi; Toshiki Ochi; Taichi Azuma; Takashi Ishida; Sachiko Okamoto; Junichi Mineno; Kiyotaka Kuzushima; Hiroshi Shiku; Masaki Yasukawa
Journal:  Blood       Date:  2013-05-02       Impact factor: 22.113
View more
  6 in total

Review 1.  Clinical and Public Health Implications of Human T-Lymphotropic Virus Type 1 Infection.

Authors:  Nicolas Legrand; Skye McGregor; Rowena Bull; Sahar Bajis; Braulio Mark Valencia; Amrita Ronnachit; Lloyd Einsiedel; Antoine Gessain; John Kaldor; Marianne Martinello
Journal:  Clin Microbiol Rev       Date:  2022-02-23       Impact factor: 50.129

2.  Increased incidence of adult T cell leukemia-lymphoma and peripheral T cell lymphoma-not otherwise specified with limited improvement in overall survival: a retrospective analysis using data from the population-based Osaka Cancer Registry.

Authors:  Shigeo Fuji; Shuhei Kida; Kayo Nakata; Toshitaka Morishima; Isao Miyashiro; Jun Ishikawa
Journal:  Ann Hematol       Date:  2020-10-21       Impact factor: 3.673

Review 3.  Updates in lymph node and skin pathology of adult T-cell leukemia/lymphoma, biomarkers, and beyond.

Authors:  Brian D Adkins; Juan C Ramos; Meghan Bliss-Moreau; Alejandro A Gru
Journal:  Semin Diagn Pathol       Date:  2019-12-20       Impact factor: 3.464

4.  Development of a modified prognostic index for patients with aggressive adult T-cell leukemia-lymphoma aged 70 years or younger: possible risk-adapted management strategies including allogeneic transplantation.

Authors:  Shigeo Fuji; Takuhiro Yamaguchi; Yoshitaka Inoue; Atae Utsunomiya; Yukiyoshi Moriuchi; Kaoru Uchimaru; Satsuki Owatari; Takashi Miyagi; Jun Taguchi; Ilseung Choi; Eiichi Otsuka; Sawako Nakachi; Hisashi Yamamoto; Saiko Kurosawa; Kensei Tobinai; Takahiro Fukuda
Journal:  Haematologica       Date:  2017-03-24       Impact factor: 9.941

Review 5.  A Review of New Findings in Adult T-cell Leukemia-Lymphoma: A Focus on Current and Emerging Treatment Strategies.

Authors:  Olivier Hermine; Juan Carlos Ramos; Kensei Tobinai
Journal:  Adv Ther       Date:  2018-02-06       Impact factor: 3.845

6.  Allogeneic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma-Romanian Experience.

Authors:  Alina D Tanase; Andrei Colita; Oana G Craciun; Lavinia Lipan; Zsofia Varady; Laura Stefan; Adela Ranete; Sergiu Pasca; Horia Bumbea; Mihaela Andreescu; Viola Popov; Alexandru Bardas; Daniel Coriu; Anca Roxana Lupu; Ciprian Tomuleasa; Anca Colita; Olivier Hermine
Journal:  J Clin Med       Date:  2020-07-28       Impact factor: 4.241
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.